Recombinant Escherichia coli Uncharacterized protein ycbX (ycbX)

Shipped with Ice Packs
In Stock

Description

Functional Role

YcbX operates in a MoCo-dependent pathway to neutralize mutagenic base analogs. Key activities include:

  • Substrate Reduction: Catalyzes the reaction:
    N⁶-Hydroxyadenine + reduced electron carrierAdenine + oxidized carrier + H2O\text{N⁶-Hydroxyadenine + reduced electron carrier} \rightarrow \text{Adenine + oxidized carrier + H}_2\text{O} .

  • Collaboration with Redox Partners: Requires NADPH-flavin reductase CysJ for electron transfer .

Table 2: Enzymatic Activity

ParameterValue/DescriptionSource
Specific ActivityEC₅₀ = 40.54–47.97 µg/mL (ELISA binding assay)
Detoxification TargetsHAP, AHAP, hydroxylamine
InhibitorsMoCo biosynthesis mutants (e.g., moaE, mobA)

Recombinant Production

Recombinant YcbX is expressed in E. coli with the following specifications:

Table 3: Expression and Purification

ParameterDetails
Expression HostE. coli K-12
VectorpQE80 or pASK-IBA5C
Purity>85% (SDS-PAGE)
StorageTris/PBS buffer with 5–50% glycerol; lyophilized powder available
Reconstitution0.1–1.0 mg/mL in sterile water; 50% glycerol for long-term storage

Mechanistic Insights

X-ray absorption spectroscopy (XAS) revealed:

  • Oxidized State (Mo⁶⁺): Two terminal oxo ligands (Mo=O\text{Mo=O}) at 1.73 Å and three sulfur donors .

  • Reduced State (Mo⁴⁺): One oxo ligand and a protonated equatorial oxygen (Mo–OH\text{Mo–OH}) .

Genetic Knockout Phenotypes

  • ΔycbX mutants: Hypersensitive to HAP and hydroxylamine, with increased mutagenesis rates .

  • Synergy with *yiiM*: Double mutants (ΔycbX ΔyiiM) show enhanced sensitivity, indicating overlapping detox pathways .

Applications and Implications

  • Bioremediation: Potential use in neutralizing environmental toxins .

  • Drug Metabolism: Insights into prodrug activation mechanisms in humans .

Product Specs

Form
Lyophilized powder. We will ship the format we have in stock. If you have specific format requirements, please note them when ordering, and we will fulfill your request.
Lead Time
Delivery time varies based on purchase method and location. Consult your local distributor for specific delivery times. All proteins are shipped with standard blue ice packs. If you require dry ice shipping, please inform us in advance, and additional charges will apply.
Notes
Avoid repeated freezing and thawing. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening to collect contents at the bottom. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on several factors: storage conditions, buffer components, storage temperature, and protein stability. Generally, the liquid form has a shelf life of 6 months at -20°C/-80°C. The lyophilized form has a shelf life of 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type will be determined during the manufacturing process. If you have a specific tag type requirement, please inform us, and we will prioritize developing the specified tag.
Synonyms
ycbX; b0947; JW5126; Uncharacterized protein YcbX
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-369
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Escherichia coli (strain K12)
Target Names
ycbX
Target Protein Sequence
MATLIRLFIH PVKSMRGIGL THALADVSGL AFDRIFMITE PDGTFITARQ FPQMVRFTPS PVHDGLHLTA PDGSSAYVRF ADFATQDAPT EVWGTHFTAR IAPDAINKWL SGFFSREVQL RWVGPQMTRR VKRHNTVPLS FADGYPYLLA NEASLRDLQQ RCPASVKMEQ FRPNLVVSGA SAWEEDRWKV IRIGDVVFDV VKPCSRCIFT TVSPEKGQKH PAGEPLKTLQ SFRTAQDNGD VDFGQNLIAR NSGVIRVGDE VEILATAPAK IYGAAAADDT ANITQQPDAN VDIDWQGQAF RGNNQQVLLE QLENQGIRIP YSCRAGICGS CRVQLLEGEV TPLKKSAMGD DGTILCCSCV PKTALKLAR
Uniprot No.

Q&A

What is the basic structure and function of ycbX protein in Escherichia coli?

ycbX is a multidomain molybdenum-containing enzyme belonging to the MOSC (Moco Sulfurase C-terminal) family of proteins. Unlike its eukaryotic counterparts, E. coli ycbX forms homodimers and contains both Mo-(MPT) (molybdopterin) and a [2Fe2S] cluster as prosthetic groups. The protein is involved in redox reactions and appears to function in N-hydroxylaminopurine resistance pathways .

Current structural understanding reveals that ycbX lacks a published crystal structure, but spectroscopic data indicates its active site contains a molybdenum center with distinct coordination environments depending on oxidation state. The enzyme is reduced by its electron transfer partner CysJ in E. coli cellular environments .

How does the coordination environment of ycbX change with oxidation state?

X-ray absorption spectroscopy has revealed significant differences in the metal coordination environment between oxidized and reduced forms of ycbX:

Oxidation StateMo Coordination EnvironmentBond Distances
Oxidized Mo(VI)Two terminal oxo ligands, thiolate S from cysteine, two S donors from PDTMo⁶⁺-O(oxo) = 1.730 Å, Mo⁶⁺-S = 2.445 Å
Reduced Mo(IV)Single terminal oxo ligand, three S donors, non-oxo light atomMo⁴⁺-O(oxo) = 1.707 Å, Mo⁴⁺-S = 2.406 Å, Light atom = 2.194 Å

Upon reduction, the more basic equatorial oxo ligand is protonated, resulting in a bond distance that suggests either a short Mo⁴⁺-OH₂ bond or a long Mo⁴⁺-OH bond . This structural transition is crucial for the catalytic mechanism.

What approaches are recommended for recombinant expression of ycbX?

For successful recombinant expression of ycbX, researchers should consider the following methodological approach:

  • Vector selection: Use pET-based expression systems with T7 promoter for controlled induction

  • Host strain selection: E. coli BL21(DE3) or similar strains with deleted proteases

  • Induction conditions: Low temperature (16-20°C) induction with reduced IPTG concentrations (0.1-0.5 mM) to improve protein folding

  • Media supplementation: Addition of molybdate and iron sources to ensure proper cofactor incorporation

  • Growth conditions: Consider microaerobic conditions to maintain proper redox environment for metal center formation

The "as-isolated" ycbX described in the literature typically contains a mixture of oxidation states, with the enzyme not being completely oxidized by air during cell lysis and protein isolation .

What purification strategy yields functionally active ycbX protein?

A multi-step purification strategy is recommended:

  • Initial capture: Affinity chromatography (typically His-tag based) under reducing conditions

  • Intermediate purification: Ion exchange chromatography to separate differentially charged species

  • Polishing: Size exclusion chromatography to isolate the dimeric form and remove aggregates

  • Buffer considerations: Maintain reducing conditions with agents like DTT or β-mercaptoethanol throughout purification

  • Activity verification: Confirm enzyme activity using benzamidoxime or other suitable substrates

To obtain homogeneous oxidation states for experimental purposes, researchers can either incubate the as-isolated enzyme with excess substrate (benzamidoxime) to generate fully oxidized Mo(VI) enzyme, or treat with dithionite to produce the reduced Mo(IV) species .

How can X-ray absorption spectroscopy effectively characterize the ycbX active site?

X-ray absorption spectroscopy (XAS) has proven invaluable for determining the coordination environment of the catalytic Mo site in ycbX. The methodological approach involves:

  • Sample preparation: Prepare protein samples in different oxidation states (as-isolated, oxidized with substrate, reduced with dithionite)

  • XANES analysis: Collect X-ray absorption near-edge structure data to determine:

    • Rising edge energies (20016.2 eV for oxidized, 20015.4 eV for as-isolated, and 20012.5 eV for reduced states)

    • Pre-edge "oxo-edge" transition features at approximately 20004 eV

  • EXAFS analysis: Analyze extended X-ray absorption fine structure data to determine:

    • Bond distances to oxygen and sulfur ligands

    • Coordination numbers

    • Potential structural heterogeneity

XANES provides information about oxidation state and effective nuclear charge, while EXAFS reveals precise bond distances and coordination geometry .

What complementary spectroscopic techniques should be used alongside XAS?

For comprehensive characterization of ycbX, researchers should combine multiple spectroscopic approaches:

  • Electron Paramagnetic Resonance (EPR): To detect potential Mo(V) intermediates, though the literature indicates as-isolated ycbX does not contain detectable Mo(V) species

  • UV-Visible Spectroscopy: To monitor redox transitions and substrate binding

  • Circular Dichroism: To assess secondary structure integrity

  • Resonance Raman: To probe metal-ligand vibrations and confirm coordination environment

  • Mass Spectrometry: For protein characterization and potential post-translational modifications

This multi-technique approach provides complementary structural information beyond what XAS alone can reveal.

How should researchers design activity assays for ycbX?

Based on its classification as an N-hydroxylaminopurine resistance protein, ycbX activity assays should consider:

  • Substrate selection: Test N-hydroxylated compounds like benzamidoxime (confirmed substrate ) and structural analogs

  • Reaction conditions:

    • Buffer: Typically phosphate or MOPS at pH 6.5-7.5

    • Temperature: 25-37°C

    • Reducing agents: Required for enzyme function

    • Electron donors: Include physiological partner CysJ or artificial electron donors

  • Detection methods:

    • Spectrophotometric assays monitoring substrate depletion or product formation

    • HPLC or LC-MS to quantify reaction products

    • Coupled enzyme assays to detect electron transfer

Control experiments should include enzyme-free reactions, heat-inactivated enzyme, and assays without electron donors to validate specific activity.

What approaches are recommended for investigating ycbX's physiological role?

To determine the physiological function of ycbX in E. coli, researchers should employ a multi-faceted approach:

  • Genetic manipulation:

    • Generate clean deletion mutants (ΔycbX)

    • Create complementation strains with wild-type and site-directed mutants

    • Develop regulated expression systems for controlled ycbX levels

  • Phenotypic characterization:

    • Growth curves under various conditions (carbon sources, stress conditions)

    • Sensitivity to N-hydroxylated compounds and other potential toxins

    • Metabolomic profiling to identify accumulated or depleted metabolites

  • Protein interaction studies:

    • Co-immunoprecipitation with known partner CysJ

    • Bacterial two-hybrid screens for additional partners

    • In vitro reconstitution of electron transfer chains

Proteomics data indicate ycbX levels change in response to certain conditions, with a log2 fold change of -0.44 observed in specific experimental setups .

How does ycbX compare to other MOSC family enzymes?

Comparative analysis of ycbX with other MOSC domain proteins reveals important structural and functional differences:

FeatureE. coli ycbXEukaryotic mARCPlant mARC1
SizeLarger, multidomainSmall, monomericIntermediate
Prosthetic groupsMo-(MPT) and [2Fe2S]Only PDT/MPTOnly PDT/MPT
Quaternary structureHomodimerMonomericMonomeric
Crystal structureNot availableHuman mARC1 availableNot available
Active site (oxidized)Di-oxo site with Mo⁶⁺-O and three S donorsNot clearly definedSimilar to SO with two S atoms of PDT, S from cysteine, two terminal oxo ligands

Despite these differences, the active site coordination environment in oxidized ycbX shows similarities to both plant mARC1 and sulfite oxidase family enzymes, suggesting potential mechanistic conservation .

What is known about the electron transfer mechanism of ycbX?

The electron transfer mechanism for ycbX involves:

  • Electron donor: CysJ serves as the physiological electron transfer partner in E. coli cells

  • Redox centers: Electrons likely flow through the [2Fe2S] cluster to the Mo center

  • Mo redox cycling: Between Mo(VI) and Mo(IV) states during catalysis

  • Substrate interaction: Benzamidoxime and potentially other N-hydroxylated compounds

The precise electron transfer pathway and kinetics remain areas for further investigation, as does the coupling between electron transfer and substrate transformation.

How can researchers interpret heterogeneity in as-isolated ycbX preparations?

The heterogeneity observed in as-isolated ycbX preparations presents specific analytical challenges:

  • Source of heterogeneity: As-isolated ycbX contains a mixture of Mo(IV) and Mo(VI) oxidation states

  • Proposed mechanism: Recombinant ycbX is reduced by CysJ in E. coli cells and remains reduced due to the low redox potential of the cytosol. Upon cell lysis, incomplete air oxidation results in the mixed oxidation state

  • Resolution approach: Researchers can obtain homogeneous samples by:

    • Incubating with excess substrate (benzamidoxime) to generate fully oxidized enzyme

    • Treating with dithionite to produce fully reduced enzyme

  • Analytical considerations: XANES spectra can distinguish between oxidation states based on edge energies and pre-edge features

Unlike other enzymes like plant nitrate reductase or MsrP where heterogeneity relates to altered coordination environments, ycbX heterogeneity appears to be simply a mixture of two well-defined oxidation states .

What controls are essential for accurate interpretation of ycbX functional studies?

When designing ycbX functional studies, the following controls are critical:

  • Oxidation state controls:

    • Fully oxidized samples (substrate-treated)

    • Fully reduced samples (dithionite-treated)

    • As-isolated mixed-state samples for comparison

  • Activity controls:

    • Enzyme-free reactions to account for non-enzymatic transformations

    • Heat-inactivated enzyme to verify enzymatic nature of reactions

    • Active site variants (e.g., coordination sphere mutations) to confirm mechanistic hypotheses

  • Specificity controls:

    • Substrate analogs to determine structural requirements

    • Inhibitor studies to confirm active site accessibility

    • Related MOSC enzymes to assess functional conservation

These controls help distinguish genuine ycbX activity from artifacts and provide mechanistic insights into the protein's function.

What structural biology approaches might overcome the lack of ycbX crystal structure?

Given the current absence of a crystal structure for ycbX, researchers should consider these alternative structural biology approaches:

These approaches could help overcome the challenges that have prevented successful crystallization of the full-length protein to date.

What systems biology approaches could reveal ycbX's role in cellular networks?

To position ycbX within broader cellular networks, researchers should employ:

  • Multi-omics integration:

    • Transcriptomic analysis of ycbX expression patterns

    • Proteomics to identify co-regulated proteins

    • Metabolomics to detect altered metabolites in ycbX mutants

  • Network analysis:

    • Protein-protein interaction networks centered on ycbX and CysJ

    • Regulatory network mapping to identify transcriptional control

    • Metabolic flux analysis to determine pathway impacts

  • Condition-specific profiling:

    • Stress responses (oxidative, nitrosative, metal limitation)

    • Growth on different carbon or nitrogen sources

    • Environmental conditions relevant to E. coli ecology

Proteomics data already suggest ycbX regulation may be connected to iron transport processes, with proteins related to iron transport showing significant changes in abundance when ycbX function is altered .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.